Blue test tubes arranged in a line, disappearing into the background

Drug news

Alcon acquires North American rights to Finafloxacin for Ear Infections.

Read time: 1 mins

Last updated: 28th Jan 2012

Published: 28th Jan 2012

Source: Pharmawand

Alcon has acquired from Singapore company, MerLion Pharma, exclusive rights in North America to an otic formulation of finafloxacin for use in ear infections, including acute otitis externa (outer ear and ear canal) and acute otitis media (middle ear) infections.Drug is in Phase II.

Learning Zone Homepage

Respiratory Syncytial Virus (RSV) in Adults

Learn more about respiratory syncytial virus (RSV) in adults. Explore RSV diagnosis, management, treatment and the burden of RSV on the patient.

Learning Zone Homepage

Fluid Management Learning Zone

Welcome to the Fluid Management Learning Zone. In this Learning Zone we provide an overview of fluid management, including albumin for sepsis and septic shock, guidelines for fluid management in liver cirrhosis and fluid management in cardiac surgery.

How do you prefer to access medical updates and information?

Listen to a podcast

Watch a video

Read an article

Other

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Drug news

Moderna reports H5 Flu data

Moderna’s H5 flu vaccine shows strong immune response in Phase 1/2; HHS ends late-stage funding, new paths explored.

Drug news

Cibotercept in PAH ends

Published: 30th May 2025

Drug news

Khindivi cleared for pediatrics

Published: 30th May 2025

See all news